Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 1,730 Castle Biosciences, Inc. shares (Form 4)

Traded Aug 17, 2026 · Filed Aug 19, 2026

On Aug 17, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 1,730 Castle Biosciences, Inc. shares at US$29.59 for US$51,191 under a trading plan, leaving 75,964 shares. Filed Aug 19, 2026 (Form 4).

Sold
1,730 shares
Price
US$29.59
Value
US$51,191
Holding after
75,964 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 17, 2026Common StockSale1,730US$29.5975,964Direct

Source

View original at SEC

Related